pentobarbital will reduce the level or result of buprenorphine, very long-performing injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. People who transfer to buprenorphine very long-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers ought to be monitored to be